Skip to main content

Table 2 Post-bronchodilator spirometry test results in salbutamol and Fluticasone/salmeterol groups

From: Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator

Variables

Salbutamol

(n = 209)

Fluticasone/Salmeterol

(n = 206)

P-value

FEV1 (L)

   

Normal

Overweight

Obese

3.27 ± 1.71

3.04 ± 0.97

2.89 ± 1.12

3.85 ± 1.75

3.41 ± 1.22

3.37 ± 1.14

0.051

0.148

0.013*

FEV1% of predicted

   

Normal

Overweight

Obese

95.28 ± 12.7

91.65 ± 14.7

89.93 ± 12.61

97.86 ± 11.9

95.32 ± 12.3

96.42 ± 11.34

0.221

0.116

0.002*

FEV1/FVC (%)

   

Normal

Overweight

Obese

79.23 ± 17.2

78.64 ± 12.9

74.31 ± 15.3

83.32 ± 16.4

82.7 ± 14.9

79.6 ± 14.2

0.156

0.093

0.0354*

Positive Reversibility test

n (%)

17 (8.1)

32 (15.6)

0.018*

  1. FEV1: Forced expiratory volume in 1 s; FVC: Forced vital capacity